Inflammatory bowel disease (IBD) in rural and urban India: results from community colonoscopic evaluation of more than 30,000 symptomatic patients
Banerjee R. et al, (2023), The Lancet Regional Health - Southeast Asia
Long-Read Single-Cell Sequencing Using scCOLOR-seq.
Philpott M. et al, (2023), Methods Mol Biol, 2632, 259 - 267
LONG-TERM SAFETY OF BUROSUMAB IN ADULTS WITH X-LINKED HYPOPHOSPHATAEMIA (XLH) IN A PHASE 3B OPEN-LABEL STUDY
Javaid MK. et al, (2023), AGING CLINICAL AND EXPERIMENTAL RESEARCH, 35, S70 - S70
Longitudinal antibody and T-cell kinetics over four doses of COVID-19 vaccination and predictors of poor response in patients with multiple myeloma
Agarwal G. et al, (2023), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 23, S248 - S249
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.
Md Yusof MY. et al, (2023), Rheumatol Adv Pract, 7
Mature primary human osteocytes in mini organotypic cultures secrete FGF23 and PTH1-34-regulated sclerostin.
Knowles HJ. et al, (2023), Front Endocrinol (Lausanne), 14
MOBILITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH PAEDIATRIC-ONSET HYPOPHOSPHATASIA TREATED WITH ASFOTASE ALFA: INTERIM ANALYSIS FROM THE UK MANAGED ACCESS AGREEMENT
Moss K. et al, (2023), AGING CLINICAL AND EXPERIMENTAL RESEARCH, 35, S254 - S254
MOBILITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH PAEDIATRIC-ONSET HYPOPHOSPHATASIA TREATED WITH ASFOTASE ALFA: INTERIM ANALYSIS FROM THE UK MANAGED ACCESS AGREEMENT
Moss K. et al, (2023), AGING CLINICAL AND EXPERIMENTAL RESEARCH, 35, S45 - S45
Modeling and Assessing Osteoarthritis in Mice by Destabilization of the Medial Meniscus (DMM).
Miotla-Zarebska J. et al, (2023), 2598, 357 - 373
One-year Anti-Osteoporosis Medication Use in Patients Identified by an AI-enabled Vertebral Fracture Pathway in the Fracture Liaison Service Setting
Eckert R. et al, (2023), JOURNAL OF BONE AND MINERAL RESEARCH, 38, 161 - 161
ORGANISATIONAL PREDICTORS OF HIGHER PERFORMING FRACTURE LIAISON SERVICE: A CLUSTER ANALYSIS OF THE FLSDB AUDIT OF ENGLAND AND WALES
Shrestha R. and Javaid MK., (2023), AGING CLINICAL AND EXPERIMENTAL RESEARCH, 35, S460 - S460
OTHER ANTIOSTEOPOROSIS AGENTS AND FRACTURE HEALING
Javaid K., (2023), AGING CLINICAL AND EXPERIMENTAL RESEARCH, 35, S107 - S108
PATIENT RECOVERY FOLLOWING HIP FRACTURE IS ASSOCIATED WITH MULTIPLE MODIFIABLE COMPONENTS OF HOSPITAL SERVICE DELIVERY IN ENGLAND AND WALES: THE REDUCE RECORD-LINKAGE COHORT STUDY
Patel R. et al, (2023), AGING CLINICAL AND EXPERIMENTAL RESEARCH, 35, S304 - S305
Patient-reported symptoms and diagnostic journey in Multiple Myeloma.
Vijjhalwar R. et al, (2023), Front Oncol, 13
Patient-reported symptoms and diagnostic journey in multiple myeloma
Vijjhalwar R. et al, (2023), BRITISH JOURNAL OF HAEMATOLOGY, 201, 71 - 71
Quantifying Immune Cell Force Generation Using Traction Force Microscopy.
Issler M. et al, (2023), Methods Mol Biol, 2654, 363 - 373
Refracture in the first year post hip fracture in England and Wales: hospital organisational factors associated with refracture from the REDUCE recordlinkage cohort study
Gregson C. et al, (2023), JOURNAL OF BONE AND MINERAL RESEARCH, 38, 265 - 265